AV nodal ablation: Difference between revisions
| Line 25: | Line 25: | ||
Despite all this, AVNA has been associated with a reduction in all-cause mortality and cardiovascular mortality in patients with coexisting atrial fibrillation and heart failure when compared with medical therapy.<ref name="Ganesan-2012">{{Cite journal | last1 = Ganesan | first1 = AN. | last2 = Brooks | first2 = AG. | last3 = Roberts-Thomson | first3 = KC. | last4 = Lau | first4 = DH. | last5 = Kalman | first5 = JM. | last6 = Sanders | first6 = P. | title = Role of AV nodal ablation in cardiac resynchronization in patients with coexistent atrial fibrillation and heart failure a systematic review. | journal = J Am Coll Cardiol | volume = 59 | issue = 8 | pages = 719-26 | month = Feb | year = 2012 | doi = 10.1016/j.jacc.2011.10.891 | PMID = 22340263 }}</ref> Conversely in another study, AVNA with implantable permanent pacemakers had no significant effect on the long-term survival of patients with atrial fibrillation when compared with drug therapy.<ref name="Ozcan-2001">{{Cite journal | last1 = Ozcan | first1 = C. | last2 = Jahangir | first2 = A. | last3 = Friedman | first3 = PA. | last4 = Patel | first4 = PJ. | last5 = Munger | first5 = TM. | last6 = Rea | first6 = RF. | last7 = Lloyd | first7 = MA. | last8 = Packer | first8 = DL. | last9 = Hodge | first9 = DO. | title = Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation. | journal = N Engl J Med | volume = 344 | issue = 14 | pages = 1043-51 | month = Apr | year = 2001 | doi = 10.1056/NEJM200104053441403 | PMID = 11287974 }}</ref> | Despite all this, AVNA has been associated with a reduction in all-cause mortality and cardiovascular mortality in patients with coexisting atrial fibrillation and heart failure when compared with medical therapy.<ref name="Ganesan-2012">{{Cite journal | last1 = Ganesan | first1 = AN. | last2 = Brooks | first2 = AG. | last3 = Roberts-Thomson | first3 = KC. | last4 = Lau | first4 = DH. | last5 = Kalman | first5 = JM. | last6 = Sanders | first6 = P. | title = Role of AV nodal ablation in cardiac resynchronization in patients with coexistent atrial fibrillation and heart failure a systematic review. | journal = J Am Coll Cardiol | volume = 59 | issue = 8 | pages = 719-26 | month = Feb | year = 2012 | doi = 10.1016/j.jacc.2011.10.891 | PMID = 22340263 }}</ref> Conversely in another study, AVNA with implantable permanent pacemakers had no significant effect on the long-term survival of patients with atrial fibrillation when compared with drug therapy.<ref name="Ozcan-2001">{{Cite journal | last1 = Ozcan | first1 = C. | last2 = Jahangir | first2 = A. | last3 = Friedman | first3 = PA. | last4 = Patel | first4 = PJ. | last5 = Munger | first5 = TM. | last6 = Rea | first6 = RF. | last7 = Lloyd | first7 = MA. | last8 = Packer | first8 = DL. | last9 = Hodge | first9 = DO. | title = Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation. | journal = N Engl J Med | volume = 344 | issue = 14 | pages = 1043-51 | month = Apr | year = 2001 | doi = 10.1056/NEJM200104053441403 | PMID = 11287974 }}</ref> | ||
The currect ACC/AHA/ESC guidelines for the management of atrial fibrillation clearly stated that AVNA should serve as the last resort when AF can not be controlled pharmacologically or when tachycardia-mediated cardiomyopathy is suspected, but nowadays in medical practice, this procedure is gradually been faded out due to a number of reasons. First is the issue of the interventricular dyssynchrony which is | |||
The currect ACC/AHA/ESC guidelines for the management of atrial fibrillation clearly stated that AVNA should serve as the last resort when AF can not be controlled pharmacologically or when [[tachycardia-mediated cardiomyopathy]] is suspected, but nowadays in medical practice, this procedure is gradually been faded out due to a number of reasons. First is the issue of the interventricular dyssynchrony which is an adverse effect of the right ventricular pacing. Other reasons are related to the fact that the patient still has AF, and will continue to require anti-coagulation coupled with regular hospital visits, the risk of strokes, and the denial of one's right to take advantage of the future medical advances since the procedure is irreversible. In fact, some centers have limited this procedure to the elderly patients - above 70 years in whom all medical treatments have been proven abortive. | |||
==References== | ==References== | ||
Revision as of 00:07, 6 September 2013
|
WikiDoc Resources for AV nodal ablation |
|
Articles |
|---|
|
Most recent articles on AV nodal ablation Most cited articles on AV nodal ablation |
|
Media |
|
Powerpoint slides on AV nodal ablation |
|
Evidence Based Medicine |
|
Cochrane Collaboration on AV nodal ablation |
|
Clinical Trials |
|
Ongoing Trials on AV nodal ablation at Clinical Trials.gov Trial results on AV nodal ablation Clinical Trials on AV nodal ablation at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on AV nodal ablation NICE Guidance on AV nodal ablation
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on AV nodal ablation Discussion groups on AV nodal ablation Patient Handouts on AV nodal ablation Directions to Hospitals Treating AV nodal ablation Risk calculators and risk factors for AV nodal ablation
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for AV nodal ablation |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ayokunle Olubaniyi, M.B,B.S [2]
Synonyms and keywords: AVNA
Overview
Atrioventricular nodal or AV junction ablation is a procedure by which the electrical pathways that connect the atria to the ventricles are modified or interrupted in order to restore a normal cardiac rhythm. This procedure creates a disconnect between the upper chambers (which controls the heart rate and rhythm) and the lower chambers (ventricles). Due to the invasive nature of this procedure and the requirement of a pacemaker implantation, AVNA is mostly done as a fallback treatment in patients with atrial fibrillation that is refractory to medications, or have developed side effects to the medications. It is important to note that this procedure is not a cure for the atrial fibrillation, its function is to regulate the ventricular rate. Therefore, patients will still require life-long anticoagulation.
Indications
- Control of ventricular rate in atrial fibrillation that is non-responsive to drug treatment.
- Recurrent symptomatic atrial tachycardia in which all therapeutic options have failed.
Procedure
Process
During this procedure, a special catheter is passed through the femoral vein into the heart under fluoroscopic guidance. Once the catheter is in place, a small amount of radiofrequency energy or heat is applied adjacent to the AV node in order to destroy it or create a scar which permanently blocks (complete AV block) the entry of fast impulses from the atrium. After a successful ablation, the ventricles will no longer respond to impulses from the atria. In other words, they beat independently of each other. The ventricular rate is about 40 beats per minute which may be too slow for adequate perfusion under exercise conditions, therefore, an implantation of a permanent pacemaker is required. The choice of pacemaker depends on the overall clinical status of the patient. This could be a single chamber versus a dual chamber ventricular pacemaker. A single chamber pacemaker may be adequate for a patient with chronic atrial fibrillation while a patient with paroxysmal AF may require a dual chamber pacemaker.
Risks of The Procedure
The procedure is relatively safe, but there are some risks associated with the procedure either during or after the procedure. They are:
- Cardiac tamponade - This occurs in less than 1% of cases. The catheter electrode may perforate the heart causing a collection of blood around the heart. This may require the insertion of a drain to remove the blood.
- Damage to the blood vessels - Occasionally, the blood vessels may be perforated by the catheter electrode.
- Iatrogenic pneumothorax - The lung wall may be punctured resulting into leakage of air into the pleural space. This may require a drain in order to re-inflate the lungs.
- Other risks include but not limited to hemorrhage at the operation site, hemothorax, pulmonary embolism, stroke, but these are extremely rare.
Complications and Prognosis
With the advent of AVNA, some complications have been reported including the development of inappropriate sinus tachycardia[1] which occurs when radiofrequency ablation in the anterior, mid, and posterior regions of the low interatrial septum disrupts the parasympathetic fibers destined to innervate the sinus node. Some episodes of ventricular fibrillation[2] have also been reported. Also, a very rare case of an acquired ventriculo-atrial shunt (between the left ventricle and the right atrium (Gerbode defect) was reported.[3] Some patients with AVNA and right ventricular pacing (pacemaker situated in the right ventricle) experience interventricular dyssynchrony which involves the right ventricle contracting before the left ventricle. This condition, which causes a reduction in left ventricular output or result in mortality, may require cardiac resynchronization therapy (CRT).
Despite all this, AVNA has been associated with a reduction in all-cause mortality and cardiovascular mortality in patients with coexisting atrial fibrillation and heart failure when compared with medical therapy.[4] Conversely in another study, AVNA with implantable permanent pacemakers had no significant effect on the long-term survival of patients with atrial fibrillation when compared with drug therapy.[5]
The currect ACC/AHA/ESC guidelines for the management of atrial fibrillation clearly stated that AVNA should serve as the last resort when AF can not be controlled pharmacologically or when tachycardia-mediated cardiomyopathy is suspected, but nowadays in medical practice, this procedure is gradually been faded out due to a number of reasons. First is the issue of the interventricular dyssynchrony which is an adverse effect of the right ventricular pacing. Other reasons are related to the fact that the patient still has AF, and will continue to require anti-coagulation coupled with regular hospital visits, the risk of strokes, and the denial of one's right to take advantage of the future medical advances since the procedure is irreversible. In fact, some centers have limited this procedure to the elderly patients - above 70 years in whom all medical treatments have been proven abortive.
References
- ↑ Kocovic, DZ.; Harada, T.; Shea, JB.; Soroff, D.; Friedman, PL. (1993). "Alterations of heart rate and of heart rate variability after radiofrequency catheter ablation of supraventricular tachycardia. Delineation of parasympathetic pathways in the human heart". Circulation. 88 (4 Pt 1): 1671–81. PMID 8403312. Unknown parameter
|month=ignored (help) - ↑ Geelen, P.; Brugada, J.; Andries, E.; Brugada, P. (1997). "Ventricular fibrillation and sudden death after radiofrequency catheter ablation of the atrioventricular junction". Pacing Clin Electrophysiol. 20 (2 Pt 1): 343–8. PMID 9058872. Unknown parameter
|month=ignored (help) - ↑ Sharma, AK.; Chander, R.; Singh, JP. (2011). "AV nodal ablation-induced Gerbode defect (LV-RA Shunt)". J Cardiovasc Electrophysiol. 22 (11): 1288–9. doi:10.1111/j.1540-8167.2011.02111.x. PMID 21649778. Unknown parameter
|month=ignored (help) - ↑ Ganesan, AN.; Brooks, AG.; Roberts-Thomson, KC.; Lau, DH.; Kalman, JM.; Sanders, P. (2012). "Role of AV nodal ablation in cardiac resynchronization in patients with coexistent atrial fibrillation and heart failure a systematic review". J Am Coll Cardiol. 59 (8): 719–26. doi:10.1016/j.jacc.2011.10.891. PMID 22340263. Unknown parameter
|month=ignored (help) - ↑ Ozcan, C.; Jahangir, A.; Friedman, PA.; Patel, PJ.; Munger, TM.; Rea, RF.; Lloyd, MA.; Packer, DL.; Hodge, DO. (2001). "Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation". N Engl J Med. 344 (14): 1043–51. doi:10.1056/NEJM200104053441403. PMID 11287974. Unknown parameter
|month=ignored (help)